GSE129698 SYK inhibition 6 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE129698_SYK inhibition_6_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE129698_SYK inhibition_6_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE129698_SYK inhibition_6_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE129698_SYK inhibition_6_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

lysine demethylase 5D

Gene

CEA cell adhesion molecule 6

Gene

transforming growth factor beta induced

Gene

pleckstrin homology like domain family A member 1

Gene

complement C3

Gene

dehydrogenase/reductase 2

Gene

protein kinase cAMP-dependent type II regulatory subunit beta

Gene

cell adhesion molecule 1

Gene

aldehyde dehydrogenase 1 family member A3

Gene

sortilin related receptor 1

  • Gene

    lysine demethylase 5D


  • Gene

    CEA cell adhesion molecule 6


  • Gene

    transforming growth factor beta induced


  • Gene

    pleckstrin homology like domain family A member 1



  • Gene

    dehydrogenase/reductase 2


  • Gene

    protein kinase cAMP-dependent type II regulatory subunit beta


  • Gene

    cell adhesion molecule 1


  • Gene

    aldehyde dehydrogenase 1 family member A3


  • Gene

    sortilin related receptor 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.